Sanofi P/B Ratio
Sanofi (SANOFI) P/B ratio is 8.56 (High), book value per share ₹374.35 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. Compare with SANOFI fair value to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2024)
Valuation Signal
Sector Context
SANOFI P/B Ratio — Valuation Insights & Book Value Analysis
Sanofi price-to-book ratio interpretation, valuation status and historical context — current P/B 8.56 (High). For live price, earnings yield and the full fundamental profile, see Sanofi share price today.
- Stock appears overvalued with PB of 8.56, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 47.8% below historical average
- Trading at premium to sector average PB of -0.33
Sanofi P/B Ratio Historical Trend
SANOFI annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View SANOFI annual price range for the annual high/low range and current price position.
SANOFI Historical P/B Ratio — Book Value Per Share & Year-End Price
Sanofi annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2024 | 16.36 | ₹374.35 | ₹6122.65 | ₹861 | High |
| 2023 | 16.41 | ₹441.3 | ₹7241.45 | ₹1,015 | High |
SANOFI vs Healthcare Peers — P/B Ratio Comparison
Sanofi P/B 8.56 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |